Increasing the efficiency of small-molecule drug discovery.

Published on Sep 1, 2003in Drug Discovery Today6.88
· DOI :10.1016/S1359-6446(03)02747-8
Barry A. Bunin13
Estimated H-index: 13
  • References (15)
  • Citations (9)
📖 Papers frequently viewed together
17 Citations
20 Citations
84 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
111 CitationsSource
#1Lars Naerum (Novo Nordisk)H-Index: 10
#2Leif Nørskov-Lauritsen (Novo Nordisk)H-Index: 6
Last. Preben H. Olesen (Novo Nordisk)H-Index: 22
view all 3 authors...
Using a virtual screening strategy based on a methodology derived from the CATS molecular descriptor, a novel compound class with inhibitory activity against the GSK-3 enzyme was identified through scaffold hopping. These compounds were readily synthesized, either by solid-phase or solution-phase chemistry. Compounds with inhibitory activity below 1 μM were identified.
54 CitationsSource
#1David J. Diller (Princeton University)H-Index: 6
#2Kenneth M. Merz (Princeton University)H-Index: 55
The prioritization of the screening of combinatorial libraries is an extremely important task for the rapid identification of tight binding ligands and ultimately pharmaceutical compounds. When structural information for the target is available, molecular docking is an approach that can be used for prioritization. Here, we present the initial validation of a new rapid approach to molecular docking developed for prioritizing combinatorial libraries. The algorithm is tested on 103 individual cases...
162 CitationsSource
5 CitationsSource
3,291 CitationsSource
#1Hans-Joachim Böhm (Hoffmann-La Roche)H-Index: 26
#2Martin Stahl (Hoffmann-La Roche)H-Index: 31
Abstract Recent advances in both computational and experimental techniques now allow a very fruitful interplay of computational and combinatorial chemistry in the structure-based design of combinatorial libraries.
46 CitationsSource
Abstract The first computational structure-based drug design methods came into existence in the early 1980s and are, to an extent, still in their infancy. There have been a few successes to date. With dramatic increases in computer speed, improved accuracy in ligand scoring functions, and the advent of combinatorial chemistry, there promises to be many more. In addition, the virtual explosion in the amount of available sequence and structural information has increased the need to develop these c...
90 CitationsSource
#1Gisbert Schneider (Hoffmann-La Roche)H-Index: 52
#2Werner Neidhart (Hoffmann-La Roche)H-Index: 14
Last. Gerard Schmid (Hoffmann-La Roche)H-Index: 7
view all 4 authors...
A chemically advanced template search (CATS) based on topological pharmacophore models has been developed as a technique for virtual screening. This technique has successfully identified novel potent Ca2+ antagonists (such as 2) that have a similar activity to 1 (a known T-channel blocking agent) in a library of several hundred thousand compounds on the basis of a correlation vector representation.
401 CitationsSource
A new method of rapid pharmacophore fingerprinting (PharmPrint method) has been developed. A basis set of 10 549 three-point pharmacophores has been constructed by enumerating several distance ranges and pharmacophoric features. Software has been developed to assign pharmacophoric types to atoms in chemical structures, generate multiple conformations, and construct the binary fingerprint according to the pharmacophores that result. The fingerprint is used as a descriptor for developing a quantit...
105 CitationsSource
The efficiency of the drug discovery process can be significantly improved using design techniques to maximize the diversity of structure databases or combinatorial libraries. Here, several physicochemical descriptors were investigated to quantify molecular diversity. Based on the 2D or 3D topological similarity of molecules, the relationship between physicochemical metrics and biological activity was studied to find valid descriptors. Several compounds were selected using those descriptors from...
200 CitationsSource
Cited By9
Natural and synthetic small molecules from the NCI Developmental Therapeutics Program (DTP) were employed in molecular dynamics-based docking with DNA repair proteins whose RNA-Seq based expression was associated with overall cancer survival (OS) after adjustment for the PCNA metagene. The compounds employed were required to elicit a sensitive response (vs. resistance) in more than half of the cell lines tested for each cancer. Methodological approaches included peptide sequence alignments and h...
#1James R. White (University of Bath)H-Index: 2
#2Gareth J. Price (University of Bath)H-Index: 30
Last. Christopher G. Frost (University of Bath)H-Index: 37
view all 6 authors...
Abstract The stable benzylazido-boronate ester 1 is presented as an example of a dual-functional linker that allows the synthetically valuable boronate motif to be clicked onto other molecules under mild conditions. The utility of the azido-boronate motif as a modular building block is demonstrated in the rapid synthesis of drug-like structures employing sequential catalytic azide–alkyne cycloaddition and Suzuki coupling reactions.
22 CitationsSource
Abstract Drug discovery companies are coming under increasing pressure to prove the long-term safety of their products more precisely, and to provide more data on them. As highlighted by Vioxx, for many drugs, the existence of adverse drug reactions (ADRs) becomes apparent once the compound has been extensively prescribed and a population base of considerable size has been exposed to the therapeutic agent. The ability to make decisions regarding termination of clinical development of a non-viabl...
11 CitationsSource
The Human Immunodeficiency Virus Type 1 Protease (HIV-1 PR, EC is a macromolecular target of great importance for the therapy of the Acquired Immunodeficiency Syndrome (AIDS). Major pharmaceutical companies around the world concentrate several efforts on studies concerning this enzyme, which since saquinavir (Invirase) reached the market in 1995, has maintained its status as a fundamental target for antiHIV drug discovery. HIV-1 protease has a rich history of enormous success in the d...
#1Marcus Koppitz (Schering AG)H-Index: 2
#2Knut Eis (Schering AG)H-Index: 2
With the advent of high throughput technologies in biological screening in the 1980s, providing sufficient numbers of small molecules for screening became a bottleneck in the drug discovery process. Combinatorial chemistry was the first attempt by chemists to address this issue. However, since its first applications, combinatorial chemistry has evolved rapidly into diverse fields. This review will focus on the evolution and the current status of what we refer to today as automated medicinal chem...
17 CitationsSource
#1Arsia Amir-Aslani (University of Paris)H-Index: 2
#2Syoum Negassi (University of Paris)H-Index: 4
Abstract The demand for innovative and cost-effective products has had considerable impact on the Research and Development (R&D) portfolio of pharmaceutical companies. With the advent of the new enabling technologies, the biotechnology revolution has created a need for a new and more appropriate paradigm for drug development. The progress in the biological understanding of disease processes and related technological developments have been a major step forward for drug discovery. However, the gre...
41 CitationsSource
In recent years, there have been significant developments made in the way new drugs are being discovered and developed. Such changes are driven by new technologies that have expanded the opportunities to prepare and screen large libraries of compounds in a rapid time frame by the use of high-throughput synthesis and screening techniques [1-3]. These strategies are driven by the need to shorten time lines for bringing discovery leads to the market [4,5]. As a result, the role and needs of synthet...
22 CitationsSource